2. Signaling Pathways
  3. Others
  4. Drug Intermediate

Drug Intermediate

Drug Iintermediate

Drug intermediates are used as raw materials for the production of bulk drugs, or they can refer to a material produced during synthesis of an API that must undergo further molecular change or processing before it becomes an API. Drug intermediates are hygienically formulated using high grade raw materials and they are used in the pharmaceutical and cosmetic industry[1][2].

Drug Intermediate Related Products (4380):

Cat. No. Product Name Effect Purity Chemical Structure
  • HY-Z8335
    Clarithromycin impurity 3
    Clarithromycin impurity 3 is an impurity of Clarithromycin.
    Clarithromycin impurity 3
  • HY-23875R
    Metformin impurity 1 (Standard)
    Metformin impurity 1 (Standard) is the analytical standard of Metformin impurity 1 (HY-23875). This product is intended for research and analytical applications.
    Metformin impurity 1 (Standard)
  • HY-185595
    N,3-BisBoc-L-Histidine
    N,3-BisBoc-L-Histidine is a Hyt hydrophobic group. N,3-BisBoc-L-Histidine can be used in the synthesis of BCR-ABL degrader 1 (HY-180798).
    N,3-BisBoc-L-Histidine
  • HY-I0677
    Regorafenib impurity 8
    		99.09%
    Regorafenib Impurity 8 is an impurity of Regorafenib (HY-10331).
    Regorafenib impurity 8
  • HY-W743945
    Itraconazole impurity 19
    Itraconazole impurity 19 is an impurity of Itraconazole.
    Itraconazole impurity 19
  • HY-W436573
    Paliperidone impurity 12
    Paliperidone impurity 12 (Paliperidone N-oxide) is an impurity of Paliperidone.
    Paliperidone impurity 12
  • HY-Z5984
    Cetirizine impurity 9 hydrochloride
    Cetirizine impurity 9 hydrochloride is an impurity of Cetirizine hydrochloride.
    Cetirizine impurity 9 hydrochloride
  • HY-W741656B
    (E)-Betamethasone impurity 4
    E-Betamethasone impurity 4 is an impurity of E-Betamethasone.
    (E)-Betamethasone impurity 4
  • HY-Z17611
    Itraconazole impurity 12
    Itraconazole impurity 12 is an impurity of Itraconazole.
    Itraconazole impurity 12
  • HY-W636076
    Azilsartan impurity 11
    Azilsartan impurity 11 is an impurity of Azilsartan.
    Azilsartan impurity 11
  • HY-W416464
    Moxifloxacin impurity 6 hydrobromide
    Moxifloxacin impurity 6 hydrobromide (8-Hydroxymoxifloxacin hydrobromide) is an impurity of Moxifloxacin hydrobromide.
    Moxifloxacin impurity 6 hydrobromide
  • HY-Z8334
    Clarithromycin impurity 2
    Clarithromycin impurity 2 is an impurity of Clarithromycin.
    Clarithromycin impurity 2
  • HY-Z8188
    Haloperidol impurity 13
    Haloperidol impurity 13 (Haloperidol octanoate) is an impurity of Haloperidol.
    Haloperidol impurity 13
  • HY-Z19591
    Everolimus impurity 7
    Everolimus impurity 7 is an impurity of Everolimus.
    Everolimus impurity 7
  • HY-W702473
    Mesalazine impurity 6
    Mesalazine impurity 6 is an impurity of Mesalazine.
    Mesalazine impurity 6
  • HY-W015805
    3-Pyridylamide oxime
    3-Pyridylamide oxime is a synthetic intermediate useful for pharmaceutical synthesis.
    3-Pyridylamide oxime
  • HY-W703245
    Rivastigmine impurity 8
    Rivastigmine impurity 8 is an impurity of Rivastigmine.
    Rivastigmine impurity 8
  • HY-Z8246
    Progesterone impurity 4
    Progesterone impurity 4 (20-Dihydroprogesterone Acetate) is an impurity of Progesterone.
    Progesterone impurity 4
  • HY-50522
    2-Methyl-1H-pyrrolo[2,3-b]pyridine
    		≥98.0%
    2-Methyl-1H-pyrrolo[2,3-b]pyridine is a heterocyclic organic compound that can be used as a drug intermediate to construct complex molecules, such as BMS-645737, a VEGFR-2 inhibitor.
    2-Methyl-1H-pyrrolo[2,3-b]pyridine
  • HY-Z8428
    Thioridazine impurity 3
    Thioridazine impurity 3 (Thioridazine disulfone) is an impurity of Thioridazine.
    Thioridazine impurity 3